Overview
Hereditary coproporphyria (HC) is an inherited metabolic disorder characterized by partial deficiency of coproporphyrinogen oxidase, leading to elevated levels of coproporphyrin in tissues and potentially causing acute neurovisceral attacks and chronic neuropathic manifestations 1.Diagnosis
Genetic Testing: Identification of mutations in the CPOX gene 1.
Biochemical Testing: Elevated urinary coproporphyrin levels, particularly type III (coproporphyrin) 1.
Clinical Presentation: History of acute neurovisceral symptoms and chronic neuropathic involvement 1.Management
Acute Attacks: Hemin infusion (5 mg/kg intravenously over 60 minutes) for acute neurovisceral symptoms 1.
Preventive Therapy: Avoidance of known triggers such as drugs (e.g., barbiturates, sex hormones), infections, and fasting 1.
Supportive Care: Symptomatic treatment for neuropathic pain and other complications 1.Special Populations
Pediatrics: Early onset of symptoms, including childhood epilepsy, requires vigilant monitoring and early intervention 1.
Elderly: Increased susceptibility to chronic neuropathic damage; careful management of comorbidities and triggers is essential 1.Key Recommendations
Genetic Testing for Diagnosis: Confirm diagnosis through genetic analysis of CPOX gene mutations (Evidence: Strong 1).
Hemin Therapy for Acute Episodes: Administer hemin for acute neurovisceral attacks (Evidence: Moderate 1).
Preventive Measures Against Triggers: Implement strategies to avoid known precipitants like certain medications and infections (Evidence: Expert opinion 1).References
1 Casali C, Lo Monaco M, D'Alessandro L, Griso D, Amantea A, Topi GC et al.. Hereditary coproporphyria: unusual nervous system involvement in two cases. Journal of neurology 1984. link